Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Solid Tumor × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Urinary Bladder Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Sarcoma 1 Primary Myelofibrosis 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Leiomyosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1

Interventions

Paclitaxel 3 pembrolizumab 2 atezolizumab 2 Nivolumab 2 Docetaxel 2 ulocuplumab 1 tislelizumab 1 tazemetostat 1 tazarotene 1 seviteronel 1 rucaparib 1 romiplostim 1 phosphorylethanolamine 1 pertuzumab 1 neratinib 1 magrolimab 1 fluzoparib 1 fludarabine 1 epacadostat 1 durvalumab 1 camrelizumab 1 Trastuzumab 1 Sunitinib 1 Poly(ADP-ribose) Polymerase Inhibitors 1 LY2510924 1 EC145 1 Cyclophosphamide 1 CH5183284 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04276376 2025-12-01

ARIANES

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡